| Website | syncardia.com |
| Category | BioTech |
| Phone | (520) 545-1234 |
| info@syncardia.com | |
| Employees | |
| Founded | 2005 |
| Description | Artificial Heart Manufacturer |
| TOTAL | $18M |
| FUNDING TOTAL | $18M |
| Series B, 5/04 | $3.7M |
| Series D, 6/09 Highway 12 Ventures | $10.3M |
| Private Equity, 3/13 | $4M |
| DEBT TOTAL | $15M |
| Debt, 3/13 Athyrium Opportunities Fund | $15M |
SynCardia Systems, Inc. is the manufacturer of the CardioWest™ temporary Total Artificial Heart (TAH‑t).
It is the only FDA and CE approved temporary Total Artificial Heart in the world.
It is designed for severely ill patients with end-stage biventricular failure.
The TAH‑t serves as a bridge to human heart transplant for transplant eligible patients who are within days or even hours of death.